Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants
about
Antenatal corticosteroids for fetal lung maturation: an overview of Cochrane reviewsRepeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomesComparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infantsSurfactant for meconium aspiration syndrome in term and late preterm infantsAnimal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndromeAnimal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndromeComparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infantsNebulised surfactant in preterm infants with or at risk of respiratory distress syndromeSurfactant for pulmonary haemorrhage in neonatesEarly versus delayed selective surfactant treatment for neonatal respiratory distress syndromeResuscitation of extremely preterm infants - controversies and current evidenceThe use of surfactant in the neonatal period- the known aspects, those still under research and those which need to be investigated furtherPhysiological, Biochemical, and Biophysical Characterization of the Lung-Lavaged Spontaneously-Breathing Rabbit as a Model for Respiratory Distress SyndromeAnalysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatmentThe Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.Early prophylactic versus late selective use of surfactant for respiratory distress syndrome in very preterm infants: a collaborative study of 53 multi-center trials in Korea.Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?In vitro surfactant and perfluorocarbon aerosol deposition in a neonatal physical model of the upper conducting airways.Development and validation of a simple algorithm for initiation of CPAP in neonates with respiratory distress in MalawiThe role of surfactant in respiratory distress syndromeRandomised controlled trial of weaning strategies for preterm infants on nasal continuous positive airway pressure.European perspective on less invasive surfactant administration-a survey.Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial.Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies.Short- and intermediate-term outcomes of preterm infants receiving positive pressure ventilation in the delivery room.Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.Efficacy and safety of surfactant replacement therapy for preterm neonates with respiratory distress syndrome in low- and middle-income countries: a systematic review.Use of evidence based practices to improve survival without severe morbidity for very preterm infants: results from the EPICE population based cohort.Is facility based neonatal care in low resource setting keeping pace? A glance at Uganda's National Referral HospitalSurvival predictors of preterm neonates: Hospital based study in Iran (2010-2011).Application of continuous positive airway pressure in the delivery room: a multicenter randomized clinical trial.The Efficacy of Surfactant Replacement Therapy in the Growth-Restricted Preterm Infant: What is the Evidence?Prophylactic versus Early Rescue Surfactant Treatment in Preterm Infants Born at Less than 30 Weeks Gestation or with Birth Weight Less than or Equal 1,250 Grams.Golden 60 minutes of newborn's life: Part 1: Preterm neonate.Saving Newborn Babies - The Benefits of Interventions in Neonatal Care in Norway over More Than 40 Years.Surfactant for Respiratory Distress Syndrome: New Ideas on a Familiar Drug with Innovative Applications.Golden hour of neonatal life: Need of the hour.Update of minimally invasive surfactant therapy.Achieving and maintaining lung volume in the preterm infant: from the first breath to the NICU.Use and timing of surfactant administration: impact on neonatal outcomes in extremely low gestational age infants born in Canadian Neonatal Intensive Care Units.
P2860
Q24185978-DC9779DC-6E11-451F-9C92-5E8881F23878Q24186565-80AAF345-2449-4010-8DDA-82EF8B862D62Q24187014-E595CB90-4989-4B03-B174-C0F085AC734BQ24187318-F01D2FD2-F32D-4B2E-9463-E5507D01E83FQ24187777-95C0BEAA-00E5-4C50-A9A8-2EA0B51EC9B3Q24187839-75892636-EA56-4E42-98F5-6777EE459905Q24197942-4627F292-9229-4140-B2A0-202A5DE54332Q24198153-65A0C14A-FBDF-4CB5-AF77-11EA99CE0FEFQ24201963-9AFA8525-894B-4126-9B7B-D265F6A7D6AFQ24202890-B909E31D-2C6A-45C0-B8CB-AE9643429D65Q26750495-04DD2AB8-C76F-4A34-B417-1A276D09BB36Q26864160-A8921850-A41B-4F28-8EBD-170EE42A4509Q28468426-13D49618-A5CA-486E-944F-8D51951599EEQ33603819-E6EFA743-2962-4668-B34D-7AE3DE9AEA2FQ33711647-99789A1F-6243-41A8-B96D-FDC88885E177Q34030003-B051DDC0-7EC0-4FA8-BDF8-2A70BE3F691BQ35013615-0EA88E67-F190-44F1-A598-E15AFAF953F9Q35248188-8127F14C-38F9-4633-89A8-90A856D17636Q35793431-443C9602-E6DC-4E9D-896F-5AF50127B827Q36131235-1CF89245-C26B-43C3-B524-F7FF8024CD85Q36135575-BC472C30-03A7-4192-B7C5-862EAA5121B2Q36220353-97E8EBDF-1CCB-4750-AFF7-8C8B16467DE4Q36362972-F4612676-947A-4A97-B9A8-B4D0660A7185Q36445514-F9F8FB14-5B8D-4F22-91EF-271CE9F6CBF2Q36582583-CE123D2D-EC6F-4A9D-939D-E69879BF9FBBQ36676402-20E22D06-9A0A-495A-9F12-66DA55DAD47EQ36846504-D229EBEE-E346-4962-952E-500674E86308Q37067336-1969A0E1-9A19-4F51-A8BD-483E336F5F89Q37196854-EA005383-BE9E-4480-92C9-20B011EC23C2Q37615528-E1BCE285-7BAC-486E-87DF-540D165B3842Q37696802-8DDC1D8C-7E7F-437D-ADE2-5FC8E3B7012CQ38268677-D53D04EA-B65F-41FA-9C14-0E32CAB420D1Q38700545-935A90BD-07B6-4AA0-A504-7151C7023A6BQ39008948-27CADF3F-998A-422A-B52F-B85AFA953E34Q40026944-F111732D-F85B-482A-AB95-B4C5160B6A1EQ41054291-6394479F-255E-4942-A75E-BDC1281BE240Q41716215-E42E6A32-0E6C-4687-A8E4-A5B8208EBC49Q42376024-F384BA38-7D0B-4380-B311-056DF0949AADQ47805927-ED6579B3-90E7-4649-8F1A-41A9B74D5D84Q48100135-9E1AFA2F-60DB-4AEE-BB5B-7610CC7F55A9
P2860
Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prophylactic versus selective ...... d mortality in preterm infants
@ast
Prophylactic versus selective ...... d mortality in preterm infants
@en
Prophylactic versus selective ...... d mortality in preterm infants
@en-gb
Prophylactic versus selective ...... d mortality in preterm infants
@nl
type
label
Prophylactic versus selective ...... d mortality in preterm infants
@ast
Prophylactic versus selective ...... d mortality in preterm infants
@en
Prophylactic versus selective ...... d mortality in preterm infants
@en-gb
Prophylactic versus selective ...... d mortality in preterm infants
@nl
prefLabel
Prophylactic versus selective ...... d mortality in preterm infants
@ast
Prophylactic versus selective ...... d mortality in preterm infants
@en
Prophylactic versus selective ...... d mortality in preterm infants
@en-gb
Prophylactic versus selective ...... d mortality in preterm infants
@nl
P2860
P921
P3181
P1476
Prophylactic versus selective ...... d mortality in preterm infants
@en
P2093
Colin J Morley
Maria Ximena Rojas-Reyes
P2860
P3181
P356
10.1002/14651858.CD000510.PUB2
P50
P577
2012-03-14T00:00:00Z